Last reviewed: July 16, 2026
Last updated: July 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide produces meaningful weight loss in approximately 85–90% of people who use it consistently, according to SURMOUNT and SUMMIT trial data. However, the size of weight loss and speed of results vary significantly between individuals. Understanding why some patients respond more powerfully than others helps explain whether this medication is the right fit for your goals.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
Why Tirzepatide Works for Most People But Not Everyone
Tirzepatide activates two hormone pathways: GLP-1 and GIP receptors. These pathways suppress appetite, slow stomach emptying, and increase feelings of fullness after eating. In clinical trials, patients taking tirzepatide lost 15–22% of body weight over 72 weeks, compared to 2–3% with placebo. However, this aggregate data masks wide individual variation—some patients lose 5% while others lose 30% under identical conditions.
Your genetic makeup influences how strongly your body responds to tirzepatide. Variants in the GLP1R, GIPR, FTO, and MC4R genes affect receptor sensitivity, appetite regulation, and how your brain processes satiety signals. Two people taking the same dose can experience completely different appetite suppression, energy changes, and weight loss because their genetic wiring activates these pathways with different efficiency. This is why personalizing your therapy requires more than a standard protocol.
How Your Genetics Relate to GLP-1 Pathways
The GLP1R gene controls how your GLP-1 receptors function. A specific variant (rs6923761) affects receptor expression and sensitivity to the medication. Patients with certain versions of this variant show stronger appetite suppression and faster weight loss when using tirzepatide. The GIPR variant (rs1800437) similarly influences how well your body responds to the GIP pathway activation, which is unique to tirzepatide compared to semaglutide-only therapy.
The PlexusDx Precision Peptide Genetic Test analyzes FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Mounjaro or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Lifestyle Factors That Determine Real-World Results
Genetics set the baseline, but consistent eating habits, sleep quality, and physical activity determine how fully tirzepatide's potential unfolds. Patients who reduce processed foods, drink adequate water, and aim for 6–8 hours of sleep per night see results that align with or exceed clinical trial averages. Those with irregular meal timing, poor sleep, and high stress may see slower progress despite being on the medication, because tirzepatide suppresses appetite—it does not automatically create a calorie deficit if eating patterns remain chaotic.
Tirzepatide works best when paired with habit change, not as a replacement for it. The medication reduces your drive to overeat and makes smaller portions feel satisfying, but you still choose which foods to eat and how often to move your body. Research shows that patients who log food intake or track physical activity lose 1.5–2× more weight than those who take tirzepatide passively without lifestyle attention. PlexusDx recommends combining your personalized medication plan with straightforward nutrition guidance and activity goals.
How PlexusDx Personalizes Tirzepatide Therapy for You
The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
PlexusDx Tirzepatide Injection is $289/mo month-to-month (or $249/mo on the 6-month plan) and remains flat regardless of your dose—your dose may need to go up, but your price won't. This pricing model removes barriers to optimal dosing, because cost does not force you to stay on a subtherapeutic amount. All medications come from licensed 503A compounding pharmacies, so you receive pharmaceutical-grade tirzepatide formulated specifically for your needs. HSA and FSA funds are accepted, and PlexusDx serves all 50 states without membership fees or insurance requirements.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What percentage of people lose significant weight on tirzepatide?
Approximately 85–90% of people using tirzepatide consistently experience weight loss, with average reductions of 15–22% of body weight in clinical trials. However, individual results range from 5% to 30%, meaning genetics, age, and lifestyle play major roles in whether you fall toward the higher or lower end of that spectrum.
How do I know if my body will respond well to tirzepatide?
No — the Precision Peptide Genetic Test does not predict your response to Mounjaro or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Is tirzepatide better than semaglutide for weight loss?
Tirzepatide activates two hormone pathways (GLP-1 and GIP), while semaglutide activates only GLP-1. Clinical data shows tirzepatide produces slightly greater average weight loss, but some patients respond equally well to semaglutide. Your genetic profile determines which compound will work best—this is why personalization matters more than general rankings.
What if tirzepatide isn't working after two months?
Most people need 4–8 weeks to reach an effective dose, and full results emerge over 12–16 weeks. If you are not seeing appetite suppression or weight loss by month three, your provider may adjust your dose, switch to oral tirzepatide, or recommend a dual-compound approach like GLP-Squared. PlexusDx genetic testing helps rule out poor response due to genetics versus inadequate dose escalation.
How much does PlexusDx tirzepatide cost, and is it covered by insurance?
PlexusDx Tirzepatide Injection is $289/mo month-to-month (or $249/mo on the 6-month plan) flat, regardless of your dose. Insurance is not required, and the medication is HSA/FSA eligible. PlexusDx serves all 50 states with no membership fees, making it accessible without employer or carrier approval.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Is the Average Weight Loss on Mounjaro Weekly?
Sermorelin Mounjaro Side Effects — Safety & Interactions